Hereditary Angioedema Therapeutic Market - Global Outlook and Forecast 2023-2028

Report ID: 1567107 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Hereditary Angioedema Therapeutic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hereditary Angioedema Therapeutic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hereditary Angioedema Therapeutic Overall Market Size
    2.1 Global Hereditary Angioedema Therapeutic Market Size: 2021 VS 2028
    2.2 Global Hereditary Angioedema Therapeutic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hereditary Angioedema Therapeutic Players in Global Market
    3.2 Top Global Hereditary Angioedema Therapeutic Companies Ranked by Revenue
    3.3 Global Hereditary Angioedema Therapeutic Revenue by Companies
    3.4 Top 3 and Top 5 Hereditary Angioedema Therapeutic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Hereditary Angioedema Therapeutic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hereditary Angioedema Therapeutic Players in Global Market
        3.6.1 List of Global Tier 1 Hereditary Angioedema Therapeutic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hereditary Angioedema Therapeutic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Hereditary Angioedema Therapeutic Market Size Markets, 2021 & 2028
        4.1.2 Intravenous
        4.1.3 Subcutaneous
        4.1.4 Oral
    4.2 By Type - Global Hereditary Angioedema Therapeutic Revenue & Forecasts
        4.2.1 By Type - Global Hereditary Angioedema Therapeutic Revenue, 2017-2022
        4.2.2 By Type - Global Hereditary Angioedema Therapeutic Revenue, 2023-2028
        4.2.3 By Type - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hereditary Angioedema Therapeutic Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Hereditary Angioedema Therapeutic Revenue & Forecasts
        5.2.1 By Application - Global Hereditary Angioedema Therapeutic Revenue, 2017-2022
        5.2.2 By Application - Global Hereditary Angioedema Therapeutic Revenue, 2023-2028
        5.2.3 By Application - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Hereditary Angioedema Therapeutic Market Size, 2021 & 2028
    6.2 By Region - Global Hereditary Angioedema Therapeutic Revenue & Forecasts
        6.2.1 By Region - Global Hereditary Angioedema Therapeutic Revenue, 2017-2022
        6.2.2 By Region - Global Hereditary Angioedema Therapeutic Revenue, 2023-2028
        6.2.3 By Region - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Hereditary Angioedema Therapeutic Revenue, 2017-2028
        6.3.2 US Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.3.3 Canada Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.3.4 Mexico Hereditary Angioedema Therapeutic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Hereditary Angioedema Therapeutic Revenue, 2017-2028
        6.4.2 Germany Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.4.3 France Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.4.4 U.K. Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.4.5 Italy Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.4.6 Russia Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.4.7 Nordic Countries Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.4.8 Benelux Hereditary Angioedema Therapeutic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Hereditary Angioedema Therapeutic Revenue, 2017-2028
        6.5.2 China Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.5.3 Japan Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.5.4 South Korea Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.5.5 Southeast Asia Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.5.6 India Hereditary Angioedema Therapeutic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Hereditary Angioedema Therapeutic Revenue, 2017-2028
        6.6.2 Brazil Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.6.3 Argentina Hereditary Angioedema Therapeutic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hereditary Angioedema Therapeutic Revenue, 2017-2028
        6.7.2 Turkey Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.7.3 Israel Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.7.4 Saudi Arabia Hereditary Angioedema Therapeutic Market Size, 2017-2028
        6.7.5 UAE Hereditary Angioedema Therapeutic Market Size, 2017-2028
7 Players Profiles
    7.1 BioCryst Pharma
        7.1.1 BioCryst Pharma Corporate Summary
        7.1.2 BioCryst Pharma Business Overview
        7.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Major Product Offerings
        7.1.4 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.1.5 BioCryst Pharma Key News
    7.2 Ionis Pharma
        7.2.1 Ionis Pharma Corporate Summary
        7.2.2 Ionis Pharma Business Overview
        7.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Major Product Offerings
        7.2.4 Ionis Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.2.5 Ionis Pharma Key News
    7.3 Pharming Group
        7.3.1 Pharming Group Corporate Summary
        7.3.2 Pharming Group Business Overview
        7.3.3 Pharming Group Hereditary Angioedema Therapeutic Major Product Offerings
        7.3.4 Pharming Group Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.3.5 Pharming Group Key News
    7.4 CSL Limited
        7.4.1 CSL Limited Corporate Summary
        7.4.2 CSL Limited Business Overview
        7.4.3 CSL Limited Hereditary Angioedema Therapeutic Major Product Offerings
        7.4.4 CSL Limited Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.4.5 CSL Limited Key News
    7.5 Shire
        7.5.1 Shire Corporate Summary
        7.5.2 Shire Business Overview
        7.5.3 Shire Hereditary Angioedema Therapeutic Major Product Offerings
        7.5.4 Shire Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.5.5 Shire Key News
    7.6 Attune Pharma
        7.6.1 Attune Pharma Corporate Summary
        7.6.2 Attune Pharma Business Overview
        7.6.3 Attune Pharma Hereditary Angioedema Therapeutic Major Product Offerings
        7.6.4 Attune Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.6.5 Attune Pharma Key News
    7.7 Adverum Biotechnologies
        7.7.1 Adverum Biotechnologies Corporate Summary
        7.7.2 Adverum Biotechnologies Business Overview
        7.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Major Product Offerings
        7.7.4 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.7.5 Adverum Biotechnologies Key News
    7.8 KalVista Pharma
        7.8.1 KalVista Pharma Corporate Summary
        7.8.2 KalVista Pharma Business Overview
        7.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Major Product Offerings
        7.8.4 KalVista Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
        7.8.5 KalVista Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Hereditary Angioedema Therapeutic Market Opportunities & Trends in Global Market
    Table 2. Hereditary Angioedema Therapeutic Market Drivers in Global Market
    Table 3. Hereditary Angioedema Therapeutic Market Restraints in Global Market
    Table 4. Key Players of Hereditary Angioedema Therapeutic in Global Market
    Table 5. Top Hereditary Angioedema Therapeutic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Hereditary Angioedema Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Hereditary Angioedema Therapeutic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Hereditary Angioedema Therapeutic Product Type
    Table 9. List of Global Tier 1 Hereditary Angioedema Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Hereditary Angioedema Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Hereditary Angioedema Therapeutic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Hereditary Angioedema Therapeutic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Hereditary Angioedema Therapeutic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Hereditary Angioedema Therapeutic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Hereditary Angioedema Therapeutic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Hereditary Angioedema Therapeutic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2023-2028
    Table 30. BioCryst Pharma Corporate Summary
    Table 31. BioCryst Pharma Hereditary Angioedema Therapeutic Product Offerings
    Table 32. BioCryst Pharma Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 33. Ionis Pharma Corporate Summary
    Table 34. Ionis Pharma Hereditary Angioedema Therapeutic Product Offerings
    Table 35. Ionis Pharma Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 36. Pharming Group Corporate Summary
    Table 37. Pharming Group Hereditary Angioedema Therapeutic Product Offerings
    Table 38. Pharming Group Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 39. CSL Limited Corporate Summary
    Table 40. CSL Limited Hereditary Angioedema Therapeutic Product Offerings
    Table 41. CSL Limited Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 42. Shire Corporate Summary
    Table 43. Shire Hereditary Angioedema Therapeutic Product Offerings
    Table 44. Shire Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 45. Attune Pharma Corporate Summary
    Table 46. Attune Pharma Hereditary Angioedema Therapeutic Product Offerings
    Table 47. Attune Pharma Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 48. Adverum Biotechnologies Corporate Summary
    Table 49. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offerings
    Table 50. Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
    Table 51. KalVista Pharma Corporate Summary
    Table 52. KalVista Pharma Hereditary Angioedema Therapeutic Product Offerings
    Table 53. KalVista Pharma Hereditary Angioedema Therapeutic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Hereditary Angioedema Therapeutic Segment by Type in 2021
    Figure 2. Hereditary Angioedema Therapeutic Segment by Application in 2021
    Figure 3. Global Hereditary Angioedema Therapeutic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Hereditary Angioedema Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Hereditary Angioedema Therapeutic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Hereditary Angioedema Therapeutic Revenue in 2021
    Figure 8. By Type - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 12. US Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 16. Germany Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 24. China Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 30. Brazil Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
    Figure 33. Turkey Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Hereditary Angioedema Therapeutic Revenue, (US$, Mn), 2017-2028
    Figure 37. BioCryst Pharma Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Ionis Pharma Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Pharming Group Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. CSL Limited Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Shire Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Attune Pharma Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. KalVista Pharma Hereditary Angioedema Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
69
Frequently Asked Questions
Hereditary Angioedema Therapeutic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Angioedema Therapeutic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Angioedema Therapeutic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports